Roivant Sciences authorizes $500 million share repurchase program

Published 25/06/2025, 12:44
Roivant Sciences authorizes $500 million share repurchase program

Roivant Sciences Ltd. (NASDAQ:ROIV) announced Tuesday that its board of directors has authorized a new common share repurchase program of up to $500 million. The program allows the company to buy back its common shares using available cash and cash equivalents. There is no set expiration date for the repurchase program.

This new authorization follows the company’s previous $1.5 billion share repurchase program, which was announced in April 2024 and had approximately $205 million of remaining capacity as of March 31, 2025. The earlier program has now been fully utilized.

Roivant stated that the timing and amount of any repurchases under the new program will depend on factors such as the market price of its common shares, overall business conditions, macroeconomic factors, and the availability of other investment opportunities. The company may conduct purchases through open market transactions, tender offers, privately negotiated transactions, or trading plans established under Rule 10b5-1 of the Securities Exchange Act of 1934.

The company noted that the repurchase program may be suspended or discontinued at any time and that there is no assurance regarding the number of shares that will be repurchased or the prices at which any repurchases will occur.

This information is based on a press release statement included in Roivant Sciences Ltd.’s filing with the U.S. Securities and Exchange Commission.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.